Time-in-therapeutic-range defined warfarin and standard dose direct oral anticoagulants in atrial fibrillation: Ischemic stroke, intracranial hemorrhage and death in a nationwide registry study

Back

ESC Professional Premium Access

Time-in-therapeutic-range defined warfarin and standard dose direct oral anticoagulants in atrial fibrillation: Ischemic stroke, intracranial hemorrhage and death in a nationwide registry study

Session: Atrial fibrillation and high-rate episodes: stroke prediction and prevention

Topic: Oral Anticoagulation

Speaker: Doctor M. Lehto (Helsinki, FI)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Mika Lehto

Helsinki University Hospital, Helsinki (Finland)

0 follower

7 more presentations in this session

Trends in newly diagnosed atrial fibrillation and oral anticoagulant use after cardiac surgery: a population-based analysis from Ontario, Canada

Speaker: Mr J. Lee (Toronto, CA)

Impact of bleeding events on mortality in patients with atrial fibrillation and silent left atrial thrombi: insight from the LAT trial

Speaker: Doctor M. Okada (Osaka, JP)

Dynamic change in anticoagulation pattern at age 65 years in patients with atrial fibrillation and prior low thromboembolic risk.

Speaker: Mr A. Gonzalez Garcia (Vigo, ES)

A multiple cut-off diagnostic meta-analysis to identify the atrial high-rate episodes threshold that better relates to thromboembolic events

Speaker: Doctor A. Ballatore (Turin, IT)

Age-dependent detection of Atrial Fibrillation with implantable cardiac monitors in patients with cryptogenic stroke

Speaker: Doctor T. Uhe (Leipzig, DE)

Access the full session

Atrial fibrillation and high-rate episodes: stroke prediction and prevention

Speakers: Doctor M. Lehto, Mr J. Lee, Doctor M. Okada, Mr A. Gonzalez Garcia, Doctor A. Ballatore...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources